Cargando…
The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
BACKGROUND: Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC). The Global Health Sector Strategy on Viral Hepatitis called for the elimination of hepati...
Autores principales: | Hayashi, Tomoyuki, Takeshita, Yumie, Hutin, Yvan J.-F., Harmanci, Hande, Easterbrook, Philippa, Hess, Sarah, van Holten, Judith, Oru, Ena Oghenekaro, Kaneko, Shuichi, Yurdaydin, Cihan, Bulterys, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525025/ https://www.ncbi.nlm.nih.gov/pubmed/34663473 http://dx.doi.org/10.1186/s13690-021-00693-2 |
Ejemplares similares
-
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
por: Wranke, Anika, et al.
Publicado: (2014) -
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
por: Tan, Mingjuan, et al.
Publicado: (2020) -
Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis
por: Oru, Ena, et al.
Publicado: (2021) -
Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
por: Hutin, Yvan, et al.
Publicado: (2018) -
Developing New Therapies for Delta Hepatitis: The Race Is On
por: Gençdal, Genco, et al.
Publicado: (2021)